Helping Patients with Multiple Sclerosis

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) October 25, 2010 -- Helping Patients with Multiple Sclerosis

Multiple Sclerosis (MS), also known as disseminated sclerosis or encephalomyelitis disseminate is a neurological disorder, in which a human body loses its ability to communicate the neural signals from the brain to the spinal cord.

There are various types of MS. However, there are three types that have been observed most commonly, viz., Relapsing Remitting Multiple Sclerosis (RRMS) – most common form of MS in which the patient tends to experience series of attacks followed by complete or partial remission; Secondary Progressive Multiple Sclerosis (SPMS) – starts with RRMS, with progressive attacks and no real periods of remission or recovery from symptoms; and Primary Progressive Multiple Sclerosis (PPMS) – most commonly found in men, with no real periods of remission and the condition deteriorates with time.

In scientific terms, MS is an inflammatory disease in which the body’s immune system eats away the protective sheath that covers the nerves. This interferes with the communication between the brain and the rest of the body. Ultimately, this may result in deterioration of the nerves themselves, a process that's not reversible, in majority of cases.

Presently, there is no treatment protocol approved for MS. Experimental trials of procedures such as Liberation Treatment and Plasma Exchange have shown positive results in patients suffering from MS. There are medications (mostly anti-cancer) that are also prescribed in the preliminary stage of MS. However, most doctors believe that these medications are symptomatic drugs and in some cases, can also lead to adverse effects or be poorly tolerated.

Drugs prescribed to slow down MS progression
1. Beta interferons: Mainly prescribed to a patient who suffers one attack per year of a relapsing form of MS or don’t recover well from neurological attacks. It is also recommended in cases where a patient develops new lesions or shows increasing tendency towards severe symptoms
2. Glatiramer: Mainly prescribed in cases of RRMS
3. Natalizumad: Prescribed as monthly treatments to subside the frequency of MS attacks
4. Mitoxantrone: Prescribed to patients suffering from aggressive RRMS or SPMS

Liberation Treatment

According to a whitepaper – “Multiple Sclerosis International Federation (MSIF) Statement, Chronic Cerebrospinal Venous Insufficiency (CCSVI)”, MSIF – recent experiments have shown that a phenomenon called as Chronic Cerebrospinal Venous Insufficiency (CCSVI) has shown a reported abnormality in blood drainage from the brain and the spinal cord. CCSVI is believed to contribute to the nervous system deterioration leading to damage causing MS. The risks and benefits of procedures to treat CCSVI have not been established by properly controlled clinical trials. A recent study, by Dr. Paolo Zamboni from the University of Ferrara in Italy, on 65 people with different types of MS, reported abnormal venous flow in 100% cases. The researchers also noted that patterns of venous obstruction differed between people at different stages and courses of MS although there was no clear relationship between severity of MS and extent of venous obstruction. However, further studies are still underway in order to conclusively establish a relationship between CCSVI and MS.

Liberation Treatment – a surgical procedure for treating CCSVI – has also shown positive results in a small number of patients suffering from MS. In this procedure, a balloon dilation is used to open up obstructed veins or insertion of stents into veins to help keep them open (endovascular surgery). Liberation Treatment, just like other endovascular procedures, also carries risks, such as elastic recoil, rupture of the vein and blood clots, etc. However, that does not mean that these procedures wouldn’t be established as potentially safe and effective treatment.

Plasma Exchange

According to an article – “Plasma Exchange, HealthNow New York Inc.”, Plasma exchange (PE) is a procedure in which the plasma is isolated, then discarded and replaced with a substitution fluid such as albumin. Plasma exchange is a nonspecific therapy, since the entire plasma is discarded. PE has been used in a wide variety of conditions including the treatment of neurological diseases. Laboratory abnormalities suggest that MS is an immune-mediated disease. PE has been used primarily as a technique to either shorten the duration of an acute attack or to reduce the number of acute attacks in patients suffering from MS. In plasma exchange, doctors remove the blood and mechanically separate the blood cells from the plasma (fluid). The blood cells are then mixed with a replacement solution, typically albumin or a synthetic fluid with properties of plasma, and are returned with the blood cells in the body.

aadi     aadi meditour     apollo hospital     Liberation Treatment     medical tourism india     Multiple Sclerosis india     multiple sclerosis treatment     plasma exchange